Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Aethlon Medical (AEMD) EPS (Weighted Average and Diluted) (2021 - 2025)

Aethlon Medical (AEMD) has disclosed EPS (Weighted Average and Diluted) for 6 consecutive years, with $39.77 as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, EPS (Weighted Average and Diluted) rose 213.89% year-over-year to $39.77, compared with a TTM value of -$8.58 through Mar 2025, up 77.92%, and an annual FY2025 reading of -$8.58, up 77.93% over the prior year.
  • EPS (Weighted Average and Diluted) was $39.77 for Q1 2025 at Aethlon Medical, up from -$29.48 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $39.77 in Q1 2025 and bottomed at -$34.92 in Q1 2024.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$3.21, with a median of -$1.12 recorded in 2023.
  • The sharpest move saw EPS (Weighted Average and Diluted) plummeted 3323.53% in 2024, then surged 213.89% in 2025.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$0.16 in 2021, then grew by 25.0% to -$0.12 in 2022, then plummeted by 1041.67% to -$1.37 in 2023, then crashed by 2051.82% to -$29.48 in 2024, then skyrocketed by 234.91% to $39.77 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for AEMD at $39.77 in Q1 2025, -$29.48 in Q4 2024, and -$16.11 in Q3 2024.